Middleware for patient-specific one-dose production will be procured for the Norwegian Hospital Pharmacy Trust [Sykehusapotekene HF]. This will replace the previous software called ATC Host. The middleware will contribute to achieving the goals with a closed medicine loop. This is achieved through automated conversion from the active ingredient to the product and controlled production of patient-labelled one-doses. We refer to a previously announced invitation for a market dialogue through a request for quotation in October 2022. A note was also published here and information on IMDsoft Metavision was distributed. See https://www.doffin.no/Notice/Details/2022-957650
Frist
Fristen for mottak av tilbud var 2023-03-23.
Anskaffelsen ble publisert 2023-02-14.
Leverandører
Følgende leverandører er nevnt i tildelingsbeslutninger eller andre anskaffelsesdokumenter:
Kunngjøring av konkurranse (2023-02-14) Gjenstand Anskaffelsens omfang
Tittel: Pharmacy services
Referansenummer: 2022 0043
Kort beskrivelse:
Middleware for patient-specific one-dose production will be procured for the Norwegian Hospital Pharmacy Trust [Sykehusapotekene HF]. This will replace the previous software called ATC Host. The middleware will contribute to achieving the goals with a closed medicine loop. This is achieved through automated conversion from the active ingredient to the product and controlled production of patient-labelled one-doses. We refer to a previously announced invitation for a market dialogue through a request for quotation in October 2022. A note was also published here and information on IMDsoft Metavision was distributed. See https://www.doffin.no/Notice/Details/2022-957650
Middleware for patient-specific one-dose production will be procured for the Norwegian Hospital Pharmacy Trust [Sykehusapotekene HF]. This will replace the previous software called ATC Host. The middleware will contribute to achieving the goals with a closed medicine loop. This is achieved through automated conversion from the active ingredient to the product and controlled production of patient-labelled one-doses. We refer to a previously announced invitation for a market dialogue through a request for quotation in October 2022. A note was also published here and information on IMDsoft Metavision was distributed. See https://www.doffin.no/Notice/Details/2022-957650
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Tjenester
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Apotekvirksomhet📦
Tilleggs-CPV: Farmasøytiske produkter📦 Utførelsessted
NUTS-region: Vestfold og Telemark
🏙️
Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet
A chosen middleware solution is an important element in meeting the goals for a closed medicine loop and should contribute to quality improvement, efficient use of resources, simplification of work processes, as well as efficient operation and management of the solution in close cooperation with a tenderer. A goal has also been set that the new application/middleware can be used in other hospital pharmacies in the South Eastern Norway Regional Health Trust [Helse Sør-Øst (HSØ)], and that it can also be used with other packing machines than those from Baxter. SAHF would like a system that can be expanded to other health trusts that are owned by HSØ if the need should arise.
A chosen middleware solution is an important element in meeting the goals for a closed medicine loop and should contribute to quality improvement, efficient use of resources, simplification of work processes, as well as efficient operation and management of the solution in close cooperation with a tenderer. A goal has also been set that the new application/middleware can be used in other hospital pharmacies in the South Eastern Norway Regional Health Trust [Helse Sør-Øst (HSØ)], and that it can also be used with other packing machines than those from Baxter. SAHF would like a system that can be expanded to other health trusts that are owned by HSØ if the need should arise.
The system must fulfil statutory requirements for personal protection and information security. The functionality in the system must be flexible and contribute to making the hospital pharmacies' work processes more efficient. The system must always be in accordance with the current laws and rules, and it must be easy to configure for adjustments in work processes. It is easy to extract registered data, with good structures for data acquisition, so that further processing and analysis can be undertaken.
The system must fulfil statutory requirements for personal protection and information security. The functionality in the system must be flexible and contribute to making the hospital pharmacies' work processes more efficient. The system must always be in accordance with the current laws and rules, and it must be easy to configure for adjustments in work processes. It is easy to extract registered data, with good structures for data acquisition, so that further processing and analysis can be undertaken.
The middleware will communicate with the basket system that is in use in HSØ. This is IMDsoft Metavision. The doctor prescribes medicines to patients through the basket system on the active ingredient level, not the product level. Furthermore the middleware must be able to communicate with different production machines in order to start production of patient-specific one-doses. These are the two most important integrations. We would like access control through single-sign-on, based on the role the person has. We use basic data connected to medicines from the FEST/SAFEST database, but we can also look are reusing master data here from other sources that already use FEST. We would like stock status updates to be visible in the middleware. We envisage obtaining this directly from the stock management systems (ERP).
The middleware will communicate with the basket system that is in use in HSØ. This is IMDsoft Metavision. The doctor prescribes medicines to patients through the basket system on the active ingredient level, not the product level. Furthermore the middleware must be able to communicate with different production machines in order to start production of patient-specific one-doses. These are the two most important integrations. We would like access control through single-sign-on, based on the role the person has. We use basic data connected to medicines from the FEST/SAFEST database, but we can also look are reusing master data here from other sources that already use FEST. We would like stock status updates to be visible in the middleware. We envisage obtaining this directly from the stock management systems (ERP).
A central functionality of the middleware will be converting prescriptions (for the active ingredient) into a commercial product that we can package as patient-labelled single doses/a product that can be dispensed and delivered to the Hospital Pharmacy by post.
A central functionality of the middleware will be converting prescriptions (for the active ingredient) into a commercial product that we can package as patient-labelled single doses/a product that can be dispensed and delivered to the Hospital Pharmacy by post.
A further description of the desired functionality is provided in SSA-K Annex 3 and the requirements in SSA-K Annex 1.
Important considerations that affect the purpose of the procurement (project goal):
The system
- Contribute to fulfilling the goals of the closed medicine loop, provide increased patient safety, meet information security and personal protection requirements, ensure stable operation and access to relevant competence for the maintenance and development of the system.
- Contribute to fulfilling the goals of the closed medicine loop, provide increased patient safety, meet information security and personal protection requirements, ensure stable operation and access to relevant competence for the maintenance and development of the system.
- Support an improved and more automated work process, as well as contribute to efficiency and quality control of medicine deliveries in the form of one-doses labelled for patients in the hospital. A possible added value of the system would be the possibility to pick and process orders for other commercial or prepared products (not only packaged as single doses) for a complete delivery of the medicines from the hospital pharmacy to the post.
- Support an improved and more automated work process, as well as contribute to efficiency and quality control of medicine deliveries in the form of one-doses labelled for patients in the hospital. A possible added value of the system would be the possibility to pick and process orders for other commercial or prepared products (not only packaged as single doses) for a complete delivery of the medicines from the hospital pharmacy to the post.
- Makes it possible to track the process before production. Evaluations and approvals must be made by the right person and production must only be commenced by an approved person.
- Is user friendly and has a short response time. Is in Norwegian and supports HSØ's goals for company architecture and architecture principles (see SSA-K Annex 3 and chapter 4 and 5 here)
- Has a pricing and licensing model that ensures incentives for scaling, good hospital economics, efficient operation and management of the system.
Beskrivelse av fornyelser:
The duration of the contract will be 4 years. The expected start of the adaptation of the existing system will be immediately after award of the tender, indicatively from June 2023. The contracting authority will have the option to extend the contract for a further 4 years, for a total of maximum 8 years. The contracting authority has a unilateral right throughout the maximum contract period to exercise options and extend the contract
The duration of the contract will be 4 years. The expected start of the adaptation of the existing system will be immediately after award of the tender, indicatively from June 2023. The contracting authority will have the option to extend the contract for a further 4 years, for a total of maximum 8 years. The contracting authority has a unilateral right throughout the maximum contract period to exercise options and extend the contract
Beskrivelse av opsjoner:
The contracting authority will have the option to extend the contract for a further 4 years, for a total of maximum 8 years. The contracting authority has a unilateral right throughout the maximum contract period to exercise options and extend the contract. The options exercised at any given time are automatically extended on verbatim terms unless the Contracting Authority takes other initiatives. The exercise of each option will have to be approved by SAHF management based on a cost estimate from the tenderer. For a description of the options, please refer to the tender documentation.
The contracting authority will have the option to extend the contract for a further 4 years, for a total of maximum 8 years. The contracting authority has a unilateral right throughout the maximum contract period to exercise options and extend the contract. The options exercised at any given time are automatically extended on verbatim terms unless the Contracting Authority takes other initiatives. The exercise of each option will have to be approved by SAHF management based on a cost estimate from the tenderer. For a description of the options, please refer to the tender documentation.
Juridisk, økonomisk, finansiell og teknisk informasjon Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten: Please see Part 1 The tender documentation
Økonomisk og finansiell stilling: Please see Part 1 The tender documentation
Teknisk og faglig kapasitet: Please see Part 1 The tender documentation
Prosedyre
Rettslig grunnlag: 32014L0024
Tidspunkt for mottak av tilbud: 12:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: engelsk 🗣️
norsk 🗣️ + 1 til
nordsamisk 🗣️
Tilbudets gyldighetsperiode: 2023-06-23 📅
Dato for åpning av tilbud: 2023-03-23 📅
Tidspunkt for åpning av tilbud: 12:00
Sted: Oslo
Utfyllende informasjon Klageinstans
Navn: Oslo TIngrett
Poststed: Oslo
Land: Norge 🇳🇴 Organ ansvarlig for meklingsprosedyrer
Navn: Koka
Poststed: Bergen
Tjeneste hvor informasjon om klageprosedyren kan innhentes
Navn: Sykehusapotekene hf
Postadresse: Biskop Gunnerus' gate 14A
Postnummer: 0185
E-post: eysteinch@sykehusapotekene.no📧
Kilde: OJS 2023/S 035-103713 (2023-02-14)
Kunngjøring om tildeling av kontrakt (2023-08-08) Gjenstand Anskaffelsens omfang
Kort beskrivelse:
Middleware for patient-specific one-dose production will be procured for the Norwegian Hospital Pharmacy Trust [Sykehusapotekene HF]. This will replace the previous software called ATC Host. The middleware will contribute to achieving the goals with a closed medicine loop. This is achieved through automated conversion from the active ingredient to the product and controlled production of patient-labelled one-doses. The contest had a deadline of 13.04.23, and is published here https://doffin.no/Notice/Details/2023-608689
Middleware for patient-specific one-dose production will be procured for the Norwegian Hospital Pharmacy Trust [Sykehusapotekene HF]. This will replace the previous software called ATC Host. The middleware will contribute to achieving the goals with a closed medicine loop. This is achieved through automated conversion from the active ingredient to the product and controlled production of patient-labelled one-doses. The contest had a deadline of 13.04.23, and is published here https://doffin.no/Notice/Details/2023-608689
Totalverdi for anskaffelsen: 25 000 000 NOK 💰
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt
Felles innkjøpsordliste (CPV)
Tilleggs-CPV: Medisinskprogramvare📦 Utførelsessted
NUTS-region: Oslo og Viken
🏙️
Gjenstand Anskaffelsens omfang
Beskrivelse av opsjoner:
Maintenance contract and license agreement. System development and further deployment. Extension of the agreement up to a maximum of 8 years
Prosedyre Tildelingskriterier
Kvalitetskriterium (navn): Fulfilment of requirement specifications, system description and implementation plan
Kvalitetskriterium (vekting): 30-40%
Kvalitetskriterium (navn): The Tenderer's offered additional values and proposed measures to reduce the contracting authority's risk
Kvalitetskriterium (vekting): 5-15%
Kvalitetskriterium (navn): Competence of the supplier´s key personnel
Pris (vekting): 30-40%
Tildeling av kontrakt
Dato for kontraktinngåelse: 2023-07-07 📅
Navn: Thula Nordic Source Solutions
Nasjonalt registreringsnummer: 660588-1089
Poststed: 600, Akureyri
Land: Island 🇮🇸
Totalverdi for anskaffelsen: 17 517 210 NOK 💰
Informasjon om tilbud
Antall mottatte tilbud: 3
Utfyllende informasjon Klageinstans
Navn: Oslo Tingrett
Poststed: Oslo
Organ ansvarlig for meklingsprosedyrer
Navn: Kofa
Poststed: Bergen
Kilde: OJS 2023/S 154-487269 (2023-08-08)